Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

SangStat presents new antiinflammatory candidate RDP-58

March 15, 2000

Italian research institute searches for new enzyme-inhibitory antiviral agents

March 14, 2000

Enteric-coated methylnaltrexone efficiently prevents GI effects of morphine in humans

March 13, 2000

Alizyme reports successful completion of phase I trial for IBD therapy

March 13, 2000

Yamanouchi begins rolling out Infergen in new markets

March 9, 2000

Patent covering novel HCV discovery issued to Chiron

March 7, 2000

C5 inhibitor prevents organ damage associated with GI ischemia in preclinical studies

March 6, 2000

Prepulsid labeling revised in Canada

March 6, 2000

ISIS-14803 begins phase I/II evaluation as HCV treatment

March 2, 2000

Hepatitis C vaccine candidate identified by Epimmune

March 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...